October 26, 2025
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: How stereo-correct data can de-risk AI-driven drug discovery
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Drug development > How stereo-correct data can de-risk AI-driven drug discovery
Drug development

How stereo-correct data can de-risk AI-driven drug discovery

By Newsroom
Last updated: October 19, 2025
1 Min Read
Share


Image: Wikimedia Commons (Public Domain)

Image: Wikimedia Commons (Public Domain)

In drug discovery, the difference between a breakthrough and a breakdown can be as small as the twist of a bond. Stereochemistry, the three-dimensional arrangement of atoms, governs how otherwise identical molecules behave in the body: whether they bind the intended target, trigger off-targets, or get cleared in minutes rather than hours.

Adam Sanford

Adam Sanford, Ph.D.

“Shape really does matter,” said Adam Sanford, Ph.D., senior product lead at scientific…



Source link

TAGGED:AI drug designchiralitycomputational chemistrydata qualityDrug discoveryenantiomersFDA approvalMachine Learningmolecular modelingQSARstereochemistrythalidomide
Share This Article
Facebook Email Copy Link Print

HOT NEWS

Steps to Improve Press Release Distribution in Environmental Science

Environmental Science
April 9, 2025

France’s Nutropy Raises €7M for Industrialization of Animal-Free Dairy Proteins – vegconomist

Nutropy, a French food tech company producing dairy proteins such as casein through precision fermentation,…

October 26, 2025

As Part of the “AfriSummit 2024” Activities A High-Level Meeting between Uganda and Egypt to Strengthen Pharmaceutical Cooperation and Expand the African Market

A high-level meeting between Uganda and Egypt to strengthen pharmaceutical cooperation CAIRO, Egypt (AfricaNewswire.Net) —…

April 5, 2025

ضمن فعاليات “قمة إفريقيا للشؤون التنظيمية 2024” اجتماع رفيع بين أوغندا ومصر لتعزيز التعاون الدوائي وتوسيع السوق الإفريقية

اجتماع رفيع المستوى بين أوغندا ومصر لتعزيز التعاون الصيدلاني القاهرة، مصر، نوفمبر 2024 (AfricaNewswire.Net)  في…

April 5, 2025

YOU MAY ALSO LIKE

‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented

Joshua Berus, PhD Maximilian Vargas, PhD Editor’s Note: Jiwon Oh provided research support for this article. She is a Certara…

Drug development
May 30, 2025

eCTD 4.0: When & Where it will be Implemented Next

Major health authorities around the world are implementing or preparing to implement the next major version of eCTD for regulatory…

Drug development
April 12, 2025

Resistance to change still greatest barrier to AI drug discovery

Resistance to change has emerged as the biggest barrier (51%) to data innovation in the pharmaceutical industry, while lack of…

Drug development
April 5, 2025

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar]

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes | Certara …

Drug development
April 5, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

France’s Nutropy Raises €7M for Industrialization of Animal-Free Dairy Proteins – vegconomist
October 26, 2025
Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence
October 26, 2025
Stop or I’ll Soot!!! | Warren Forensics
October 26, 2025
36 recent hospital, health system executive moves
October 26, 2025

Life Science Magazines

Executive Brief: Compliant Targeting Ailment-Specific…
October 24, 2025
Webinar: Building the leadership teams that launch in Europe
October 24, 2025
How to accelerate time-to-insight with better RWD
October 24, 2025
How multimodal data is transforming drug discovery
October 23, 2025

LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?